STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
Conversions, 180 days
2
Codes C/M, not in net · $158.9K priced
What the filings say about CRBG
Insiders, 180 days
-$194.6M net sold
1 buyer · 3 sellers · 17% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$501.1M
4 notices
Corebridge Financial insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Corebridge Financial, Inc. insiders sold a net $194.6M of stock across 63 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
Nobody has filed for crossing 5%. That is a fact, not missing data.
CRBG planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Ditillo David
Filed 2026-09-11
$305.8K
Elizabeth Cropper
Filed 2026-08-19
$256.0K
Blackstone Holdings II L.P.
Filed 2026-08-10
$500.1M
Ditillo David
Filed 2026-08-06
$422.1K
Ditillo David
Filed 2026-07-16
$397.2K
Executive pay vs shareholder return · Kevin Hogan
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2023
$8.6M
$12.1M
$4.0M
+24%
+19%
2022
$8.9M
$14.2M
$4.3M
-1%
+9%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $194.6M sold by insiders over 180 days, $501.1M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$20.1B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM CRBG
FY Dec 2025
$18.5B
FY Dec 2024
$18.8B
FY Dec 2023
$18.9B
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
$3.9B
Mar 2026
$4.0B
Dec 2025
$6.8B
Sep 2025
$5.4B
Jun 2025
$2.7B
Mar 2025
$3.6B
Dec 2024
$6.6B
Sep 2024
$2.6B
At each fiscal year end
Single quarter
Net margin, TTM
+4.5%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM CRBG
FY Dec 2025
-2.0%
FY Dec 2024
+11.9%
FY Dec 2023
+5.8%
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
+0.1%
Mar 2026
-1.3%
Dec 2025
+12.0%
Sep 2025
+2.7%
Jun 2025
-24.1%
Mar 2025
-18.5%
Dec 2024
+32.8%
Sep 2024
-45.3%
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
capex not filed for the four quarters
Free cash flow, TTM CRBG
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Debt to equity
0.86x
long-term 2022-12-31 (42 months older than the period end) plus current 2026-06-30; equity 2026-06-30
Debt to equity CRBG
FY Dec 2025
0.60x
FY Dec 2024
0.78x
FY Dec 2023
0.69x
FY Dec 2022
1.00x
FY Dec 2021
0.32x
Jun 2026
0.86x
Mar 2026
0.73x
Dec 2025
0.60x
Sep 2025
0.58x
Jun 2025
0.65x
Mar 2025
0.75x
Dec 2024
0.78x
Sep 2024
0.58x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.20x
TTM operating cash flow over long-term 2022-12-31 (42 months older than the period end) plus current 2026-06-30
Cash flow to debt CRBG
FY Dec 2025
0.26x
FY Dec 2024
0.24x
FY Dec 2023
0.41x
FY Dec 2022
0.28x
FY Dec 2021
n/a
Jun 2026
0.20x
Mar 2026
0.21x
Dec 2025
0.26x
Sep 2025
0.21x
Jun 2025
0.21x
Mar 2025
0.21x
Dec 2024
0.24x
Sep 2024
0.18x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+7.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity CRBG
FY Dec 2025
-3.0%
FY Dec 2024
+19.2%
FY Dec 2023
+10.4%
FY Dec 2022
+44.6%
FY Dec 2021
n/a
Jun 2026
+7.9%
Mar 2026
+2.2%
Dec 2025
-3.0%
Sep 2025
+7.3%
Jun 2025
-2.9%
Mar 2025
+5.8%
Dec 2024
+19.2%
Sep 2024
-11.4%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+0.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets CRBG
FY Dec 2025
-0.1%
FY Dec 2024
+0.6%
FY Dec 2023
+0.3%
FY Dec 2022
+2.1%
FY Dec 2021
n/a
Jun 2026
+0.2%
Mar 2026
+0.1%
Dec 2025
-0.1%
Sep 2025
+0.2%
Jun 2025
-0.1%
Mar 2025
+0.2%
Dec 2024
+0.6%
Sep 2024
-0.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital CRBG
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed CRBG
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
21.47x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing CRBG
FY Dec 2025
n/a
FY Dec 2024
8.31x
FY Dec 2023
12.38x
FY Dec 2022
1.59x
FY Dec 2021
n/a
Jun 2026
18.01x
Mar 2026
55.49x
Dec 2025
n/a
Sep 2025
21.37x
Jun 2025
n/a
Mar 2025
31.57x
Dec 2024
8.31x
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no cash line filed
Enterprise value CRBG
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
capex not filed for the four quarters
FCF yield CRBG
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
prior-year trailing EPS was a loss, growth undefined
PEG, trailing CRBG
FY Dec 2025
n/a
FY Dec 2024
0.08x
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
0.08x
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
CRBG ranks highest on insider conviction (31st percentile) and risk and compliance (28th), and lowest on growth (16th), among Insurance peers.
Profitability
23
Inputs
Return on equity+7.9% · 28 pct, sector of 116
Return on assets+0.2% · 18 pct, sector of 122
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Financial health
19
Inputs
Debt to equity0.86x · 13 pct, sector of 104
Cash flow to debt0.20x · 25 pct, sector of 97
Growth
16
Inputs
Revenue growth, YoY-1.2% · 16 pct, sector of 134
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
31
Inputs
Net Form 4 buying (codes P and S), 180d-$492.3M · 0 pct, sector of 100
Insider buyers, 180d1 · 62 pct, sector of 101
Risk and compliance
28
Inputs
Short interest, % of float+5.4% · 28 pct, sector of 138
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
2 not measured: Institutional and government, US patents
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
CRBG filings, in plain words
Are Corebridge Financial insiders buying or selling CRBG?
In the 180 days to 2026-10-27, Corebridge Financial insiders were net sellers, a net $194.6M: $298.0M of purchases and $492.6M of sales reported on Form 4, by 1 buyer and 3 sellers.
Are there planned insider sales of CRBG?
Yes. 4 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $501.1M of stock; the latest, by Ditillo David, was filed 2026-09-11.
Read the full summary
In the 180 days to 2026-10-27, Corebridge Financial insiders were net sellers of CRBG, a net $194.6M across purchases and sales reported on Form 4 by 1 buyer and 3 sellers. Most of that figure, $193.1M, came from a holder of 10% or more rather than an officer or director. 17% of the 6 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. Insiders filed 4 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $501.1M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.